Outcomes for multidrug-resistant tuberculosis patients with and without resistance to fluoroquinolones and second-line injectable drugs: A meta-analysis of individual patient data
G.B. Migliori, S. Ahuja, D. Ashkin, M. Avendano, R. Banerjee, M. Bauer, J. Bayona, M. Becerra, A. Benedetti, M. Burgos, R. Centis, E.D. Chan, C.Y. Chiang, H. Cox, L. D‘Ambrosio, K. DeRiemer, N.H. Dung, D. Enarson, K. Flanagan, J. Flood, M.L. Garcia-Garcia, N. Gandhi, R. Granich, M.G. Hollm-Delgado, T.H. Holtz, M. Iseman, L. Jarlsberg, S. Keshavjee, H.R. Kim, W.J. Koh, J. Lancaster, C. Lange, W.C.M. de Lange, V. Leimane, C.C. Leung, J. Li, S. Mishustin, C. Mitnick, M. Narita, P. O‘Riordan, M. Pai, D. Palmero, S.K. Park, G. Pasvol, J. Pena, C. Pérez-Guzmán, M. Quelapio, A. Ponce-de-Leon, V. Riekstina, J. Robert, S. Royce, H.S. Schaaf, K.J. Seung, L. Shah, T.S. Shim, S.S. Shin, Y. Shiraishi, J. Sifuentes-Osornio, G. Sotgiu, M.J. Strand, P. Tabarsi, T.E. Tupasi, R. van Altena, M. Van der Walt, T.S. Van der Werf, M.H. Vargas, P. Viiklepp, J. Westenhouse, W.W. Yew, J.J. Yim, D. Menzies (Tradate, Italy; Long Island City, Lantana, Rochester, Hanover, Boston, Albuquerque, Denver, Davis, Richmond, Bronx, Atlanta, San Francisco, New York, Seattle, United States Of America; Toronto, Montreal, Canada; Paris, France; Taipei City, Taiwan; Cape Town, Pretoria, Tygerberg, South Africa; Ho Chi Minh City, Viet Nam; Tasmania, Australia; Cuernavaca, Aguascalientes, Mexico City, Mexico; Geneva, Switzerland; Seoul, Masan City, Republic Of Korea; Borstel, Germany; Groningen, Netherlands; Upeslejas, Latvia; Hong Kong, Hong Kong; Tomsk, Russian Federation; London, United Kingdom; Buenos Aires, Argentina; Madrid, Spain; Makati, Philippines; , ; Tokyo, Japan; Tehran, Islamic Republic Of Iran; Tallinn, Estonia)
|    ![]()  ![]() |